Somnomed Ltd
ASX:SOM
Somnomed Ltd
Interest Income Expense
Somnomed Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Somnomed Ltd
ASX:SOM
|
Interest Income Expense
-AU$3.2m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Interest Income Expense
AU$1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Interest Income Expense
-AU$30.6k
|
CAGR 3-Years
67%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
25%
|
Cochlear Ltd
ASX:COH
|
Interest Income Expense
-AU$2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
25%
|
CAGR 10-Years
12%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Interest Income Expense
AU$243.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Interest Income Expense
-AU$35.3k
|
CAGR 3-Years
-289%
|
CAGR 5-Years
-137%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Interest Income Expense?
Interest Income Expense
-3.2m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Interest Income Expense amounts to -3.2m AUD.
What is Somnomed Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-97%
Over the last year, the Interest Income Expense growth was -605%. The average annual Interest Income Expense growth rates for Somnomed Ltd have been -61% over the past three years , -97% over the past five years .